AzTrials
AzTrials

Sleep DisturbanceNCT04400617

Sleep Quality in Assisted-Living Residents

An observational study of Sleep Disturbance and Aging, run by University of Calgary at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Assisted living residents who have sleep disturbances are at great risk of developing cognitive impairments. The identification of factors that increase sleep problems in this population is the first step towards improving sleep disorders and reducing and/or delaying the occurrence of cognitive impairments in this… Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Sleep Disturbance, Aging
What is being tested?
Cross-sectional assessments to examine the relationship among sleep quality, functional/physical capacity, and cognitive performance.
How many people
150 participants
Where
1 siteCanada
Study dates
1 Jan 2023to 31 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • Adult, Older adult

Study population: The target population will be inactive men and women residents of the Brenda Strafford Foundation (> 50 yrs. old).

Who may be able to join

  • Be inactivity, which will be defined as an engagement in < 3 sessions/week of 20 min or more of vigorous exercise;
  • Be able to move independently without the assistance of a wheelchair.

Who cannot join

  • Diagnosis of a developmental handicap;
  • Residents who are not able to understand communication and be understood by others and do not have decision-making capacity according to the Cognitive Performance Scale (CPS) > 3; The investigators will assess all the resident's capacity with the Brenda Strafford Foundation caregivers, even if their CPS is within the range included in the study (CPS 0-3);
  • Terminal illness (life expectancy < 1 year);
  • Not fluent in English;
  • Currently participating in another trial;
  • Comorbid medical or neurological illnesses (e.g., multiple sclerosis) that would confound cognitive assessments or make trial completion unlikely (in the site investigator's opinion);
  • Contraindication for the tests.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Marc J Poulin, PhD contact

403.220.8372

poulin@ucalgary.ca

Shane Magnison-Benoit, BSc contact

403.220.8372

shane.magnisonbenoit@ucalgary.ca

Canada1 site, 1 recruiting
  • University of Calgary

    Calgary, Alberta, T2N 4N1

    Recruiting

Other trials in Canada

About this study

Official title: Understanding the Association Between Sleep Quality, Physical Activity, and Memory in Assisted-Living Residents

Assisted living residents who have sleep disturbances are at great risk of developing cognitive impairments. The identification of factors that increase sleep problems in this population is the first step towards improving sleep disorders and reducing and/or delaying the occurrence of cognitive impairments in this population. Physical activity has been proposed to improve sleep quality in older individuals, but there is currently no scientific evidence of how sleep mediates the relationship between physical activity and cognition in assisted living residents. This is a cross-sectional study that investigates the relationship between sleep quality, functional/physical capacity, and cognitive performance. Participants will be recruited through a non-probabilistic sampling method (convenience) as this is a feasibility study that aims to identify, for the first time, sleep disorders in assisted living residents using objective measures of sleep. Sleep quality will be measured with polysomnography, actigraphy, and questionnaire. Functional and physical capacity will be assessed through walking tasks and actigraphy. Cognitive tasks will be used to assess memory. This study will bring new insights into the factors that affect the quality of life and sleep in assisted living residents. The evidence-based knowledge acquired on-site will be translated and shared with the local and global scientific community to raise awareness of the factors that contribute to increasing institutionalization and dependent living. Results obtained from objective and subjective measures of sleep will be of great importance to develop specialized clinical expertise and behavioral interventions that will meet residents' needs.

Read the detailed description

Specific Objectives and Hypotheses:

  1. To test the feasibility of using polysomnography to identify the severity of sleep disorders in assisted living residents. The implementation of objective measures of sleep in assisted living residents is practical and provides accurate information on sleep architecture parameters.
  2. To investigate the association between functional capacity and physical activity and sleep quality in assisted living residents using functional tests and actigraphy, respectively. There is a positive association between functional capacity and sleep quality and physical activity will improve sleep quality in the efficiency and duration domains.
  3. To investigate the association between sleep quality, measured through actigraphy, and cognitive performance, specifically in the memory domain, in assisted living residents. There is a positive association between sleep quality, especially sleep efficiency, and cognitive performance.
  4. To compare the sleep quality (measured with polysomnography, actigraphy, and questionnaire) in assisted living residents with older individuals of the same age and cognitive performance (Montreal Cognitive Assessment; MoCA score > 26) who live independently.

Sleep quality will be lower in assisted living residents in comparison with older individuals who live independently and the use of various methods to assess sleep quality will provide a better estimation of the differences in sleep quality between these populations.

Being tested
Cross-sectional assessments to examine the relationship among sleep quality, functional/physical capacity, and cognitive performance.
Keywords
Sleep, Functional Capacity, Cognitive Performance, Assisted-Living Facilities
Medical subject headings
Parasomnias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cross-sectional assessments to examine the relationship among sleep quality, functional/physical capacity, and cognitive performance.Behavioural

    The first visit will consist of screening measurements. Participants will be asked to complete the following questionnaires: InterRAI Self Report Quality of Life Survey for Long Term Care Facilities (interRAI SQoL), Resident Assessment Instrument (RAI)-MDS 2.0, Global Physical Activity Questionnaire (GPAQ), Memory Complaint Questionnaire (MAC-Q), and Pittsburgh Sleep Quality Index (PSQI). At the end of this visit, the participants will be asked to wear the ActiWatch-2 (AW-2) as a wristwatch for 14 days. In the second visit, participants' height and weight will be measured and the participants will perform the following cognitive and functional tests: MoCA, Brief Visuospatial Memory Test-Revised (BVMT-R), Hopkins Verbal Learning Test-Revised (HVLT-R), Time up and Go (TUG), and Cognitive TUG (TUGcog). Finally, visit 3 will consist of on-site PSG recordings.

Study groups in NCT04400617
Study groupRoleWhat they receive
Assisted-living residentsThe target population will be inactive men and women residents of the Brenda Strafford Foundation (> 50 yrs. old). We expect the participants to be classified as inactivity, which will be defined as an engagement in < 3 sessions/week of 20 min or more of vigorous exercise. Participants should be able to move independently without the assistance of a wheelchair.
Receives: Behavioral: Cross-sectional assessments to examine the relationship among sleep quality, functional/physical capacity, and cognitive performance.
Control groupVolunteers from the Brain in Motion II (BIM II) study (NCT03035851). The BIM II study aims to examine the mechanisms whereby exercise may improve sleep and cognition in men and women aged 50 to 80 years old. As the baseline measurements of the BIM II study are similar to the assessments proposed in this study, the assisted living residents will be matched with older individuals of the same age and cognitive performance who live independently to answer the last research question.
Receives: Behavioral: Cross-sectional assessments to examine the relationship among sleep quality, functional/physical capacity, and cognitive performance.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total sleep time.

    The Prodigy Sleep Monitor (polysomnography) and Actiwatch 2 (actigraphy) will be used to analyze this sleep outcome.

    Measured: Through study completion, an average of 1 year.

  2. Sleep efficiency.

    The Prodigy Sleep Monitor (polysomnography) and Actiwatch 2 (actigraphy) will be used to analyze this sleep outcome.

    Measured: Through study completion, an average of 1 year.

  3. Sleep onset latency.

    The Prodigy Sleep Monitor (polysomnography) and Actiwatch 2 (actigraphy) will be used to analyze this sleep outcome.

    Measured: Through study completion, an average of 1 year.

  4. Number of awakening.

    The Prodigy Sleep Monitor (polysomnography) and Actiwatch 2 (actigraphy) will be used to analyze this sleep outcome.

    Measured: Through study completion, an average of 1 year.

  5. PSQI component score.

    The Pittsburgh Sleep Quality Index (PSQI) will be used to subjectively measure sleep quality and disturbances in the past few months. The self-related questions include the assessment of seven different sleep domains: sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. The participant should score each of the seven areas from 0 (no difficulty) to 3 (severe difficulty). Final score ≥ 5 indicates poor sleep quality.

    Measured: Through study completion, an average of 1 year.

Secondary outcomes (6)
  1. Short-term memory, visuospatial ability, and executive function.

    Montreal Cognitive Assessment (MoCA) will be used.

    Measured: Through study completion, an average of 1 year.

  2. Visuo-spatial memory.

    Visuospatial Memory Test-Revised (BVMT-R) will be used.

    Measured: Through study completion, an average of 1 year.

  3. Verbal learning and memory.

    Hopkins Verbal Learning Test-Revised (HVLT-R) will be used.

    Measured: Through study completion, an average of 1 year.

  4. Functional capacity.

    Time up and Go (TUG) task will be performed. The TUG test considers the time the participant takes to stand up from a chair, walk 3 m away, return to the chair, and sit down in the chair again.

    Measured: Through study completion, an average of 1 year.

  5. Dual-task capacity.

    Cognitive TUG (TUGcog) will be performed. In the TUGcog test, the participant should perform the same task while counting backward from a randomly assigned number between 60 and 100

    Measured: Through study completion, an average of 1 year.

  6. Total number of counts (physical activity).

    The Actiwatch 2 will be used for 14 days to record total movement and patterns of activity per day.

    Measured: Through study completion, an average of 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2020
  2. Study start1 Jan 2023
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04400617
Sponsor's protocol ID
REB 19-1939
Status last verified
Apr 2026
First submitted
14 May 2020
Last updated
1 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Disturbance and Aging, run by University of Calgary at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Marc J Poulin, PhD (403.220.8372, poulin@ucalgary.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total sleep time. (time frame: Through study completion, an average of 1 year.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in